Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gout
Biotech
GRO Bio gathers $60M series B to take gout therapy into clinic
The protein therapeutics-focused biotech will use the money to push its lead gout treatment ProGly-Uricase into clinical trials.
James Waldron
Jul 19, 2024 9:59am
Selecta narrows focus to gout drug, freezing rest of pipeline
Aug 17, 2023 8:18am
Selecta, Sobi rout gout in phase 3 trials to take on Horizon
Mar 21, 2023 7:40am
Alnylam culls 3 programs, including once-touted nephropathy med
Dec 16, 2022 1:52pm
Innovent pays nearly $100M for China rights to LG Chem gout med
Dec 15, 2022 10:10am
Arrowhead pointed toward Horizon with $40M upfront for gout drug
Jun 21, 2021 10:20am
